These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36421311)

  • 21. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization.
    Chen X; Zhou M; Yan Q; Jian Z; Liu W; Li H
    J Clin Lab Anal; 2022 Nov; 36(11):e24715. PubMed ID: 36181301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
    Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
    Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
    J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.
    Salomão MC; Guimarães T; Duailibi DF; Perondi MBM; Letaif LSH; Montal AC; Rossi F; Cury AP; Duarte AJS; Levin AS; Boszczowski I
    J Hosp Infect; 2017 Nov; 97(3):241-246. PubMed ID: 28826688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
    Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
    Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

  • 34. Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?
    Yang TT; Luo XP; Yang Q; Chen HC; Luo Y; Zhao YM; Ye YS; Lai XY; Yu J; Tan YM; Wei GQ; Huang H; Shi JM
    Antimicrob Resist Infect Control; 2020 Mar; 9(1):49. PubMed ID: 32183898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?
    Tiri B; Sensi E; Marsiliani V; Cantarini M; Priante G; Vernelli C; Martella LA; Costantini M; Mariottini A; Andreani P; Bruzzone P; Suadoni F; Francucci M; Cirocchi R; Cappanera S
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perianal swabs surveillance cultures of Carbapenem-resistant Enterobacteriaceae(CRE) can be hints for CRE bloodstream infection in patients with hematological diseases].
    Xu CH; Su Y; Lyu YX; Tian ZY; Sun FJ; Lin QS; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):1021-1025. PubMed ID: 30612405
    [No Abstract]   [Full Text] [Related]  

  • 38. Carbapenem-resistant enterobacteriaceae screening: A core infection control measure for critical care unit in India?
    Ramanathan YV; Venkatasubramanian R; Nambi PS; Ramabathiran M; Venkataraman R; Thirunarayan MA; Samundeeswari P; Ramakrishnan N
    Indian J Med Microbiol; 2018; 36(4):572-576. PubMed ID: 30880709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.